Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance
13 janv. 2025 06h45 HE | Inspire Medical Systems
MINNEAPOLIS, Minn, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025
07 janv. 2025 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2024 after the close of trading...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
30 déc. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Present at Piper Sandler 36th Annual Healthcare Conference
19 nov. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
15 nov. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program
11 nov. 2024 06h45 HE | Inspire Medical Systems
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
06 nov. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook
04 nov. 2024 16h02 HE | Inspire Medical Systems
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
30 oct. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
Inspire_Primary_Logo_RGB_DAYLIGHT (002).png
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
07 oct. 2024 08h00 HE | Inspire Medical Systems
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday,...